PD-1 Immune Checkpoint Blockade Reduces Pathology and Improves Memory in Mouse Models of Alzheimer’s Disease - NeuroQuest
The latest research from the research team of NeuroQuest Founder and Chief Scientist, Dr. Michal Schwartz, published in Nature Medicine was highlighted in the U.K. Telegraph showing the potential certain cancer-fighting drugs may have in fighting Alzheimer's disease.